Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA)

Historical Holders from Q2 2021 to Q3 2025

Type / Class
Equity / Common Stock, $0.00001 par value per share
Symbol
AKYA
Shares outstanding
54,965,124
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
0
Total reported value
$0
Share change
-12,536,885
Value change
-$16,297,785
Avg sell value change
-0%
Number of holders
0
Price from insider filings
$1.25
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Quanterix Corp 56% -0.54% $38,811,973 +$3,615,179 30,560,609 +10% Quanterix Corporation 28 Apr 2025
As of 30 Sep 2025, Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) has 0 institutional shareholders filing 13F forms. They reported no common stock holdings, but disclosed options positions.

Institutional Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 0 $0 -$16,297,785 0
2025 Q2 12,538,172 $16,299,458 +$393,906 130% 57
2025 Q1 12,180,731 $16,933,516 -$396,175 139% 64
2024 Q4 12,134,199 $27,787,012 -$94,780 229% 60
2024 Q3 12,090,894 $32,886,405 -$636,504 272% 59
2024 Q2 12,385,236 $28,979,719 -$9,287,172 234% 58
2024 Q1 14,854,113 $69,665,707 +$272,730 469% 66
2023 Q4 14,746,467 $72,097,557 -$6,143,228 488% 62
2023 Q3 16,048,557 $74,626,912 -$4,377,853 465% 60
2023 Q2 16,061,952 $118,696,041 +$17,919,115 739% 72
2023 Q1 13,357,367 $109,090,839 -$6,745,365 818% 63
2022 Q4 14,068,910 $134,634,613 -$3,380,379 957% 71
2022 Q3 14,383,053 $169,004,351 +$16,199,753 1,175.01% 55
2022 Q2 12,982,721 $166,825,000 +$9,078,280 1,284.99% 52
2022 Q1 12,312,165 $135,320,000 -$258,605 1,098.88% 45
2021 Q4 12,136,619 $189,431,000 +$26,498,236 1,531% 44
2021 Q3 9,884,433 $137,984,289 -$15,853,081 1,396% 46
2021 Q2 10,064,753 $194,653,000 +$194,653,002 1,933.99% 60